Sivelestat sodium alleviates sepsis-associated acute lung injury by inhibiting ferroptosis via the Nrf2/SLC7A11/GPX4 axis
Sivelestat-Natrium lindert sepsisassoziierte akute Lungenschädigung durch Hemmung von Ferroptose über die Nrf2/SLC7A11/GPX4-Achse
PLOS One · 14.07.2026 · 21 (7) · e0353525
DOI: 10.1371/journal.pone.0353525 ↗Auf einen Blick
In einem Rattenmodell der sepsisassoziierten akuten Lungenschädigung verbesserte Sivelestat-Natrium mehrere Lungenparameter dosisabhängig. Der Schutz war mit Veränderungen der Ferroptose-assoziierten Signalwege verknüpft.
Fragestellung
Wirkt Sivelestat-Natrium therapeutisch bei sepsisassoziierter akuter Lungenschädigung und über welchen Mechanismus?
Methode
Rattenmodell der SALI mit CLP; Vergleich von Sham, CLP und Sivelestat-Natrium in niedriger, mittlerer und hoher Dosis; zusätzlich Nrf2-Inhibitor ML385 zur Mechanismusprüfung.
Ergebnisse
Gegenüber CLP verbesserten mittlere und hohe Dosis PaO2 und PaO2/FiO2; W/D-Verhältnis, Lung injury score, TNF-α, IL-1β, IL-6, SOD, GSH, Fe2+ und MDA änderten sich dosisabhängig. Nrf2, SLC7A11 und GPX4 stiegen, ACSL4 und TFR1 sanken.
Schlussfolgerung der Autor:innen
Sivelestat-Natrium verbessert SALI bei Ratten durch Hemmung von Ferroptose über die Regulation der Nrf2/SLC7A11/GPX4-Signalachse.
Kernaussagen
- Sivelestat-Natrium verbesserte in Rattenmodellen die Oxygenierung
- Effekte waren dosisabhängig, besonders bei mittlerer und hoher Dosis
- ML385 schwächte die schützenden Effekte und Signalwegänderungen ab
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 14.07.2026. Verfasst von Ying Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Nantong First People's Hospital, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Sepsis, NF-E2-Related Factor 2, Ferroptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund of Research project of Nantong Municipal Health Commission, Fund of Nantong University Special Research Fund for Clinical Medicine.
Themen: Sepsis
Abstract (Originalsprache)
Objective
This study was aimed to investigate the therapeutic efficacy and mechanism of Sivelestat sodium in sepsis-associated acute lung injury (SALI).
Methods
A rat model of SALI was established using the cecal ligation and puncture (CLP) procedure. After the model was established in rats, behavioral changes, abdominal conditions, and survival rates were monitored. Comparative analyses included arterial blood gas parameters, the lung wet/dry weight ratio (W/D), lung injury scores, histopathological damage assessment, inflammatory cytokine levels, oxidative stress marker levels, and Fe 2+ concentrations in lung tissue. The expression levels of Nrf2, SLC7A11, GPX4, ACSL4, and TFR1 proteins in pulmonary tissues were also evaluated.
Results
All rats in the sham group survived. The survival rates in the low-dose (SL), medium-dose (SM), and high-dose (SH) groups (60.0%, 73.3%, and 86.7%, respectively) were higher than those in the CLP group (53.3%), although the differences were not statistically significant. Compared to the Sham group, the CLP group showed significantly lower PaO 2 and PaO 2 /FiO 2 , higher lung wet/dry weight ratio and lung injury score, higher levels of TNF-α, IL-1β, and IL-6 in the lung tissue, lower levels of SOD and GSH, and higher levels of Fe 2+ and MDA. Additionally, the expression of Nrf2, SLC7A11, and GPX4 proteins was downregulated, whereas the expression of ACSL4 and TFR1 proteins was upregulated. Compared to the CLP group, the SL, SM, and SH groups showed higher PaO 2 and PaO 2 /FiO 2 ratios. The SM and SH groups showed lower lung tissue W/D ratios and lung injury scores, along with lower levels of TNF-α, IL-1β, and IL-6 in the lung tissue. In contrast, only the IL-6 levels were lower in the SL group. The SM and SH groups showed significantly higher SOD and GSH levels, along with considerably lower Fe 2+ and MDA levels. Notably, the SL group exhibited significant improvement only in arterial blood gas parameters and IL-6 levels, with no statistically significant differences observed in other indicators, indicating a dose-dependent response. In all Sivelestat sodium-treated groups, the expression levels of Nrf2, SLC7A11, and GPX4 proteins in rat lung tissue were upregulated, whereas the expression of ACSL4 and TFR1 proteins was downregulated. To validate the Nrf2 pathway, medium-dose Sivelestat sodium was administered with or without the Nrf2 inhibitor ML385. Sivelestat sodium upregulated total Nrf2, nuclear Nrf2, SLC7A11, and GPX4, and downregulated ACSL4 and TFR1. Co-administration of ML385 largely abolished these changes and blunted its protective effects on lung histopathology.
Conclusion
Sivelestat sodium ameliorates SALI in rats by inhibiting ferroptosis through regulation of the Nrf2/SLC7A11/GPX4 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Nantong First People's Hospital, Nantong, Jiangsu, China.
- Department of Respiratory and Critical Care Medicine, Hai'an Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nantong, Jiangsu, China.
- Department of Obstetrical, Nantong First People's Hospital, Nantong, Jiangsu, China.
- Department of Critical Care Medicine, Affiliated Hai'an Hospital of Nantong University, Hai'an County, Nantong, Jiangsu, China.
- Journal Academic Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
ORCID-Profile: Ying Wang, Jingjing Fan
Förderung
- Fund of Research project of Nantong Municipal Health Commission
- Fund of Nantong University Special Research Fund for Clinical Medicine
Zitieren
APA
Wang, Y., Xia, X., Lu, Y., Zhang, C., Zhou, Y., & Fan, J. (2026). Sivelestat sodium alleviates sepsis-associated acute lung injury by inhibiting ferroptosis via the Nrf2/SLC7A11/GPX4 axis. PLOS One, 21(7), e0353525. https://doi.org/10.1371/journal.pone.0353525
Vancouver
Wang Y, Xia X, Lu Y, Zhang C, Zhou Y, Fan J. Sivelestat sodium alleviates sepsis-associated acute lung injury by inhibiting ferroptosis via the Nrf2/SLC7A11/GPX4 axis. PLOS One. 2026;21(7):e0353525. doi:10.1371/journal.pone.0353525
BibTeX
@article{Wang2026,
author = {Wang, Ying and Xia, Xiaoling and Lu, Yan and Zhang, ChengLiang and Zhou, Yaqing and Fan, Jingjing},
title = {Sivelestat sodium alleviates sepsis-associated acute lung injury by inhibiting ferroptosis via the Nrf2/SLC7A11/GPX4 axis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0353525},
doi = {10.1371/journal.pone.0353525}
}
EUVIMED